(Q39592261)

English

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies

scientific article published on August 2000

In more languages
default values for all languages
No label defined

No description defined

Statements

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies (English)
6769-6776

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit